ProjectiFIT-ATM Kinase Inh. – Development of novel Inhibitors of ATM-kinase and their evaluation in combination with RPA3…
Basic data
Acronym:
iFIT-ATM Kinase Inh.
Title:
Development of novel Inhibitors of ATM-kinase and their evaluation in combination with RPA3 inhibitors in anti-tumor therapies.
Duration:
01/09/2019 to 31/08/2021
Abstract / short description:
Development of novel Inhibitors of ATM-kinase and their evaluation in combination with RPA3 inhibitors in anti-tumor therapies.
Involved staff
Managers
Faculty of Science
University of Tübingen
University of Tübingen
Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science
Department of Pharmacy and Biochemistry, Faculty of Science
Baden-Württemberg Center for Brazil and Latin America
Branch offices and other central facilities
Branch offices and other central facilities
Cluster of Excellence: Image-Guided and Functionally Instructed Tumor Therapies (iFIT)
Centers or interfaculty scientific institutions
Centers or interfaculty scientific institutions
Other staff
Department of Pharmacy and Biochemistry
Faculty of Science
Faculty of Science
Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science
Department of Pharmacy and Biochemistry, Faculty of Science
Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science
Department of Pharmacy and Biochemistry, Faculty of Science
Local organizational units
Pharmaceutical Institute
Department of Pharmacy and Biochemistry
Faculty of Science
Faculty of Science
Funders
Bonn, Nordrhein-Westfalen, Germany